# A PhaseⅠb Study Evaluating Safety and Efficacy of C-CAR011 Treatment in B- NHL Subjects

> **NCT03483688** · PHASE1 · COMPLETED · sponsor: **Peking Union Medical College Hospital** · enrollment: 6 (actual)

## Conditions studied

- B-cell Non-Hodgkin Lymphoma

## Interventions

- **BIOLOGICAL:** CD19-directed CAR-T cells

## Key facts

- **NCT ID:** NCT03483688
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-06
- **Primary completion:** 2019-12-10
- **Final completion:** 2020-01-10
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03483688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03483688, "A PhaseⅠb Study Evaluating Safety and Efficacy of C-CAR011 Treatment in B- NHL Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03483688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*